Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Asian Pac J Cancer Prev ; 20(10): 3071-3075, 2019 Oct 01.
Article in English | MEDLINE | ID: mdl-31653156

ABSTRACT

BACKGROUND: Treatment of cancer with chemo-radiotherapy causes severe side effects due to cytotoxic effects towards normal tissues which often results in morbidity. Therefore, developing anticancer agents which can selectively target the cancer cells and cause less side effects are the main objectives of the new therapeutic strategies for treatment advanced or metastatic cancers. Newcastle disease virus strains AF2240 and V4-UPM were shown to be cytolytic against various cancer cells in-vitro and very effective as antileukemicagents. METHODS: 45 rats at 6 weeks of age, were randomly assigned to nine groups with 5 rats in each group, both azoxymethane (AOM) and 5-Fluorouracil (5-FU) were given to rats according to the body weight. NDV virus strains (AF2240 and V4-UPM) doses were determined to rats according to CD50 resulted from MTT assay. After 8 doses of NDV strians and 5-FU, tissue sections preparations and histopathological study of rats' organs were done. RESULTS: In this article morphological changes of rats' organs, especially in livers, after treatment with a colon carcinogen (azoxymethane) and Newcastle disease virus strains have been recorded. We observed liver damage caused by AOM evidenced by morphological changes and enzymatic elevation were protected by the oncolytic viruses sections. Also we found that combination treatment NDV with 5-FU had greater antitumor efficacy than treatment with NDV or 5-FU alone. CONCLUSION: We noted morphological changes in liver and other rats' organs due to a chemical carcinogen and their protection by NDV AF2240 and NDV V4-UPM seems to be most protective.


Subject(s)
Liver Diseases/pathology , Liver Diseases/therapy , Newcastle disease virus/genetics , Oncolytic Virotherapy , Animals , Antimetabolites, Antineoplastic/toxicity , Azoxymethane/toxicity , Carcinogens/toxicity , Fluorouracil/toxicity , Liver Diseases/etiology , Newcastle disease virus/classification , Rats
2.
BMC Complement Altern Med ; 18(1): 50, 2018 Feb 05.
Article in English | MEDLINE | ID: mdl-29402248

ABSTRACT

BACKGROUND: Dracaena cinnabari (DC) is a perennial tree that located on the Southern coast of Yemen native to the Socotra Island. This tree produces a deep red resin known as the Dragon's blood, the Twobrother's Blood or Damm Alakhwain. The current study performed to evaluate the safety of the DC resin methanol extract after a single or 28 consecutive daily oral administrations. METHODS: In assessing the safety of DC resin methanol extract, acute and sub-acute oral toxicity tests performed following OECD guidelines 423 and 407, respectively, with slight modifications. In acute oral toxicity test, DC resin methanol extract administered to female Sprague Dawley rats by oral gavage at a single dose of 300 and 2000 mg/kg body weight. Rats observed for toxic signs for 14 days. In sub-acute oral toxicity test, DC resin methanol extract administered to the rats by oral gavage at 500, 1000, and 1500 mg/kg body weight daily up to 28 days to male and female Spradgue Dawley rats. The control and high dose in satellite groups were also maintained and handled as the previous groups to determine the late onset toxicity of DC resin methanol extract. At the end of each test, hematological and biochemical analysis of the collected blood were performed as well as gross and microscopic pathology. RESULTS: In acute oral toxicity, no treatment-related death or toxic signs were observed. It revealed that the DC resin methanol extract could be well tolerated up to the dose 2000 mg/kg body weight and could be classified as Category 5. The sub-acute test observations indicated that there are no treatment-related changes up to the high dose level compared to the control. Food consumption, body weight, organ weight, hematological parameters, biochemical parameters and histopathological examination (liver, kidney, heart, spleen and lung) revealed no abnormalities. Water intake was significantly higher in the DC resin methanol extract treated groups compared to the control. CONCLUSION: This study demonstrates tolerability of DC resin methanol extract administered daily for 28 days up to 1500 mg/kg dose.


Subject(s)
Dracaena/chemistry , Resins, Plant/toxicity , Administration, Oral , Animals , Body Weight/drug effects , Drinking/drug effects , Eating/drug effects , Female , Heart/drug effects , Kidney/drug effects , Male , Methanol , Organ Size/drug effects , Rats , Rats, Sprague-Dawley , Resins, Plant/administration & dosage , Toxicity Tests, Acute , Toxicity Tests, Subchronic
3.
ScientificWorldJournal ; 2014: 232535, 2014.
Article in English | MEDLINE | ID: mdl-25147841

ABSTRACT

The association between diabetes mellitus and chronic periodontal disease has long been established. Most of the researches linking these two very common chronic diseases were based on type 2 diabetes mellitus and chronic periodontal disease. However, this study was conducted to investigate the association between type 1 diabetes and chronic periodontal disease in Malaysian subjects. Forty-one Malaysian subjects, of which 20 subjects were type 1 diabetics and with chronic periodontal disease (test group) and 21 subjects with only chronic periodontal disease (control group), were included in the study. Periodontal parameters and plaque samples for microbiological evaluation were done at baseline, 2 and 3 months after nonsurgical periodontal therapy. Blood samples were taken from only the test group and evaluated for HbA1c at baseline and 3 months after periodontal therapy. There were no statistically significant difference in periodontal parameters between groups (P>0.05) and no significant improvement in the level of HbA1c in the test group. Microbiological studies indicated that there were significant reductions in the levels of the tested pathogens in both groups. The results of our study were similar to the findings of several other studies that had been done previously.


Subject(s)
Blood Glucose , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 1/microbiology , Microbiota , Periodontal Diseases/complications , Periodontal Diseases/therapy , Adult , Chronic Disease , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/drug therapy , Female , Glycated Hemoglobin/metabolism , Humans , Hypoglycemic Agents/therapeutic use , Malaysia , Male , Middle Aged , Periodontal Diseases/diagnosis , Periodontium/microbiology , Treatment Outcome
4.
ScientificWorldJournal ; 2013: 632972, 2013.
Article in English | MEDLINE | ID: mdl-24068884

ABSTRACT

Cell-based regenerative therapies, based on in vitro propagation of stem cells, offer tremendous hope to many individuals suffering from degenerative diseases that were previously deemed untreatable. Due to the self-renewal capacity, multilineage potential, and immunosuppressive property, mesenchymal stem cells (MSCs) are considered as an attractive source of stem cells for regenerative therapies. However, poor growth kinetics, early senescence, and genetic instability during in vitro expansion and poor engraftment after transplantation are considered to be among the major disadvantages of MSC-based regenerative therapies. A number of complex inter- and intracellular interactive signaling systems control growth, multiplication, and differentiation of MSCs in their niche. Common laboratory conditions for stem cell culture involve ambient O2 concentration (20%) in contrast to their niche where they usually reside in 2-9% O2. Notably, O2 plays an important role in maintaining stem cell fate in terms of proliferation and differentiation, by regulating hypoxia-inducible factor-1 (HIF-1) mediated expression of different genes. This paper aims to describe and compare the role of normoxia (20% O2) and hypoxia (2-9% O2) on the biology of MSCs. Finally it is concluded that a hypoxic environment can greatly improve growth kinetics, genetic stability, and expression of chemokine receptors during in vitro expansion and eventually can increase efficiency of MSC-based regenerative therapies.


Subject(s)
Mesenchymal Stem Cells/cytology , Cell Culture Techniques , Cell Hypoxia , Cell Proliferation , Genomic Instability , Models, Biological , Oxygen/metabolism , Reactive Oxygen Species/metabolism , Receptors, Chemokine/genetics , Receptors, Chemokine/metabolism , Receptors, Notch/metabolism , Regenerative Medicine/methods , Signal Transduction , Up-Regulation
5.
Asian Pac J Cancer Prev ; 14(11): 6273-80, 2013.
Article in English | MEDLINE | ID: mdl-24377517

ABSTRACT

Goniothalamin, a natural compound extracted from Goniothalamus sp. belonging to the Annonacae family, possesses anticancer properties towards several tumor cell lines. This study focused on apoptosis induction by goniothalamin (GTN) in the Hela cervical cancer cell line. Cell growth inhibition was measured by MTT assay and the IC50 value of goniothalamin was 3.2 ± 0.72 µg/ml. Morphological changes and biochemical processes associated with apoptosis were evident on phase contrast microscopy and fluorescence microscopy. DNA fragmentation, DNA damage, caspase-9 activation and a large increase in the sub-G1 and S cell cycle phases confirmed the occurrence of apoptosis in a time-dependent manner. It could be concluded that goniothalamin show a promising cytotoxicity effect against cervical cancer cells (Hela) and the cell death mode induced by goniothalamin was apoptosis.


Subject(s)
Apoptosis/drug effects , Caspase 9/biosynthesis , Goniothalamus/chemistry , Plant Extracts/pharmacology , Pyrones/chemistry , Pyrones/pharmacology , Caspase 9/metabolism , Cell Death/drug effects , Cell Line, Tumor , DNA Damage/drug effects , DNA Fragmentation/drug effects , Enzyme Induction , G1 Phase/drug effects , HeLa Cells , Humans , Plant Extracts/chemistry , S Phase/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...